A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 18, 2012

Primary Completion Date

December 3, 2012

Study Completion Date

December 3, 2012

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

GSK2330672

BID, repeat doses

DRUG

Placebo

BID, repeat doses

DRUG

GSK1614235

BID, co-dosed BID with last dosing day of active/placebo repeat doses

Trial Locations (1)

GSK Investigational Site, Baltimore